Markets
CS

European ADRs Marginally Lower as Pharma Stocks See Mixed Fortunes

An image of a pen and a calculator
Credit: Shutterstock photo

American depository receipts of European stocks were 0.3% lower at 121.08 on the Bank of New York Mellon Europe ADR Index on Wednesday morning.

Decliners in Continental Europe were led by CGG ( CGG ), a manufacturer of geophysical equipment, 6.0% lower, followed by Advanced Accelerator Applications ( AAAP ), a radiopharmaceutical company, down by 5.0% and Swiss financial services provider Credit Suisse ( CS ), down by 4.2%.

In the UK, pharmaceutical company Adaptimmune Therapeutics ( ADAP ) was 1.8% lower, followed by Luxfer ( LXFR ), a materials technology company, 1.6% lower and GlaxoSmithKline (GSK), a healthcare company, down by 1.3%.

Gainers in Continental Europe were led by Abengoa (ABGB), a Spanish energy conglomerate, up by 7.1%, followed by ABB (ABB), a Swiss company engaged in power and automation technologies, 0.6% higher and telecommunication major Orange (ORAN), trading 0.5% higher.

And, in the UK, Akari Therapeutics (AKTX), a development-stage biopharmaceutical company, was 3.9% higher, followed by gold miner Randgold Resources (GOLD), up by 2.3% and health care company Shire (SHPG), trading 1.8% higher.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CS ADAP LXFR

Other Topics

Stocks

Latest Markets Videos